|     home    |     search     |     content     |     mail     |     login     |

study information

date of publication15-feb-2000
journalVirology 2000 Feb 15;267(2):237-46
titleSusceptibility of in Vitro Stimulated PBMC to Infection with NSI HIV-1 Is Associated with Levels of CCR5 Expression and beta-Chemokine Production.
title in Dutch
resp. centreCLB
designSusceptibility of PHA/rIL-2-stimulated PBMC from 14 healthy blood donors for NSI HIV-1 infection was analyzed in relation to CCR5 expression and beta-chemokine production. After 1 week of culture in the presence of rIL-2, but not at the moment of inoculation, CCR5 surface expression was positively and beta-chemokine production was inversely associated with susceptibility to NSI HIV-1 infection. Surprisingly, no association was observed between CCR5 genotype and in vitro NSI HIV-1 susceptibility, which was in agreement with similar levels of CCR5 surface expression and beta-chemokine production in CCR5Delta32/+ and CCR5 +/+ PBMC after PHA/rIL-2 stimulation. In contrast to what was observed in vitro, CCR5 genotype did associate with CCR5 surface expression levels in vivo in resting as well as in activated CD4(+) T cell populations that were identified by the expression of CD45RO, CD27, HLA-DR, and CD69. The association between CCR5 expression and susceptibility to infection by NSI HIV-1 observed in vitro might offer an explanation for the in vivo observed protective effect of CCR5 polymorphisms that influence CCR5 expression on disease progression.

Use this form to to view general information about a study.
  • click on 'authors' to view the list of authors who contributed
  • click on 'files' to view a list of files, associated with this study: these files can be of any type: f.i. the full text of the article, or code used in the analysis, or a Powerpoint demonstration.
  • click on 'tables' to view a list of the database tables that were used in this study: more is information on these tables is available.
  • for studies related to the Amsterdam Cohort, the option 'progress' is available: it gives information about the process of collecting information about a study: who was asked for information, when was this done, is the information complete, etc.
  • if you have the authority to change data about the study, the option 'edit' is available: clicking this will take you to a form for editing the main information, with options to edit all aspects.
  • clicking on the PubMedID opens a new browser window with PubMed
  • clicking on the 'resp. centre' gives a list of all studies for this centre
  • click the 'back' button to go to the previous document